Biomarker Study in Participants With Migraine
Public ClinicalTrials.gov record NCT02766517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
LY2951742 Biomarker Study in Patients With Migraine
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study of participants with a diagnosis of migraine who completed another clinical trial NCT02163993. The participants received either LY2951742 or placebo. This study NCT02766517 will evaluate how certain biomarkers may be related to the participant's response in study NCT02163993. The study will last about five days.
Study identification
- NCT ID
- NCT02766517
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Early Phase 1
- Enrollment
- 37 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 28, 2016 (Actual)
- Primary completion
- Jan 1, 2017 (Actual)
- Completion
- Jan 1, 2017 (Actual)
- Last update posted
- Apr 9, 2019
2016 – 2017
United States locations
- U.S. sites
- 14
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Pharmacology Research Institute, Newport Beach | Encino | California | 91316 | — |
| Parexel Early Phase Unit at Glendale | Glendale | California | 91206-4140 | — |
| Pharmacology Research Institute, Newport Beach | Los Alamitos | California | 90720 | — |
| Pharmacology Research Institute, Newport Beach | Newport Beach | California | 92660 | — |
| Medical Center for Clinical Research | San Diego | California | 92108 | — |
| California Clinical Trials | San Diego | California | 92123 | — |
| Avail Clinical Research LLC | DeLand | Florida | 32720 | — |
| Psychiatric Inst of Florida-Clinical Neuroscience Solutions | Orlando | Florida | 32801 | — |
| PharmaSite Research Inc | Baltimore | Maryland | 21208 | — |
| PAREXEL-Phase 1 Baltimore Harbor Hospital Center | Baltimore | Maryland | 21225 | — |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | — |
| CNS Health Care | Memphis | Tennessee | 38119 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007-4209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02766517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2019 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02766517 live on ClinicalTrials.gov.